Natalie Compton
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 10%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 9
- PARP inhibition in cancer therapy 6
- Lung Cancer Research Studies 3
- HER2/EGFR in Cancer Research 2
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Kevin J. Harrington (4 shared papers)Nigel Biswas–Baldwin (3 shared papers)Iman El‐Hariry (3 shared papers)Éva Remenár (2 shared papers)Hisham Mehanna (2 shared papers)Philippe Legenne (2 shared papers)Mike Lau (2 shared papers)Martin Housset (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Molecular Cancer Therapeutics (2 papers)Annals of Oncology (2 papers)British Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Natalie Compton
13 papers receiving 412 citations
Peers
Comparison fields: 5 of 68
- Otorhinolaryngology 139
- Oncology 255
- Reproductive Medicine 62
- Pulmonary and Respiratory Medicine 164
- Cancer Research 39
Countries citing papers authored by Natalie Compton
This map shows the geographic impact of Natalie Compton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Compton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Compton more than expected).
Fields of papers citing papers by Natalie Compton
This network shows the impact of papers produced by Natalie Compton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Compton. The network helps show where Natalie Compton may publish in the future.
Co-authors
The 25 scholars most cited alongside Natalie Compton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 89 | |
| 2 | 2012 | 89 | |
| 3 | 2023 | 55 | |
| 4 | 2015 | 45 | |
| 5 | 2016 | 42 | |
| 6 | 2014 | 28 | |
| 7 | 2010 | 22 | |
| 8 | 2010 | 21 | |
| 9 | 2022 | 16 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 5 | |
| 12 | 2024 | 2 | |
| 13 | 2013 | 1 | |
| 14 | 2025 | 0 |
About Natalie Compton
Natalie Compton is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine, Surgery and Otorhinolaryngology, having authored 14 papers that have together received 421 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), PARP inhibition in cancer therapy (6 papers), Ovarian cancer diagnosis and treatment (6 papers), Lung Cancer Research Studies (3 papers), Head and Neck Cancer Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), HER2/EGFR in Cancer Research (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Otorhinolaryngology (139 citations), Oncology (255 citations), Reproductive Medicine (62 citations), Pulmonary and Respiratory Medicine (164 citations) and Cancer Research (39 citations). Natalie Compton has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Kevin J. Harrington, Nigel Biswas–Baldwin, Iman El‐Hariry, Éva Remenár, Hisham Mehanna, Philippe Legenne, Mike Lau, Martin Housset, Martin Robinson and Rejnish Kumar. Their work appears in journals such as European Journal of Cancer, Molecular Cancer Therapeutics, Annals of Oncology, British Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.